Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,481 across all filing types
Latest filing 2023-12-15 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 14 December 2023.
Director's Dealing Classification · 100% confidence The document details a transaction involving a person discharging managerial responsibilities ('Ognian Donev') concerning the sale ('Sell') of financial instruments ('Warrants') of the issuer ('Sopharma AD'). This structure, including sections for 'Details of the person discharging managerial responsibilities', 'Details of the issuer', and 'Details of the transaction(s): section to be repeated for (i) each type of instrument...', is characteristic of insider trading disclosures, specifically reporting personal share transactions by directors and executives. This aligns directly with the definition for Director's Dealing (Code: DIRS).
2023-12-15 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 14 December 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction notification concerning an individual, Ognian Donev, who is an Executive director and chairman of the Board of directors of Sopharma AD (the issuer). The notification explicitly details the 'Nature of the transaction' as 'Buy' and lists specific prices and volumes for shares (ISIN № BG11SOSOBT18). This structure—reporting personal share transactions by company directors/executives—perfectly matches the definition of a Director's Dealing report.
2023-12-15 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 13 December 2023.
Director's Dealing Classification · 100% confidence The document text consists of a structured table detailing a transaction involving a person discharging managerial responsibilities (or a closely associated person) and the issuer (Sopharma AD). Key fields include 'Name' of the associated person/entity, 'Position/status' (Executive director and chairman of the Board of directors), 'Description of the financial instrument' (Shares), 'Nature of the transaction' (Buy), and 'Price(s) and volume(s)'. This format is characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2023-12-14 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 13 December 2023.
Director's Dealing Classification · 100% confidence The document text explicitly details a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It lists the 'Details of the person discharging managerial responsibilities' (Ognian Donev), the 'Reason for the notification' (Position/status as Executive director and chairman of the Board of directors), and the 'Details of the transaction(s)' including the nature ('Sell'), price, volume, and date. This structure perfectly matches the definition of a Director's Dealing report, which tracks personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2023-12-14 English
Notification for buy-back shares
Transaction in Own Shares Classification · 100% confidence The document is a 'Current report' dated 14.12.2023 concerning 'Treasury shares'. It explicitly states that the Company 'bought 184 000 own shares' and details the total number of treasury shares held after the transaction. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The reference to Regulation (EU) No 596/2014 confirms it is a regulatory disclosure regarding share transactions.
2023-12-14 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 12 December 2023.
Director's Dealing Classification · 100% confidence The document text contains structured tables detailing a transaction involving a 'person discharging managerial responsibilities' or a 'person closely associated' (Donev Investments Holding AD in relation to Ognian Donev of Sopharma AD). It specifies the nature of the transaction as 'Buy' for 'Shares' at specific 'Price(s)' and 'volume(s)'. This format and content are characteristic of mandatory regulatory filings reporting insider transactions, specifically director's dealing or transactions by closely associated persons, as mandated by regulations like MAR (Regulation 596/2014 mentioned in the text). This directly corresponds to the definition of Director's Dealing (DIRS).
2023-12-13 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.